Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -359,639 | -201,977 | -111,190 | -45,629 | -109,963 |
| Depreciation Amortization | -8,797 | -7,160 | -5,253 | -2,998 | -16,827 |
| Accounts payable and accrued liabilities | 43,438 | -5,400 | -4,319 | -2,110 | 2,303 |
| Other Working Capital | 48,978 | -16,501 | -7,858 | -15,062 | 9,362 |
| Other Operating Activity | -2,665 | 37,643 | 29,228 | 13,468 | 27,335 |
| Operating Cash Flow | $-278,685 | $-193,395 | $-99,392 | $-52,331 | $-87,790 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 341,388 | 265,776 | 105,751 | 63,245 | -553,366 |
| Investing Cash Flow | $341,388 | $265,776 | $105,751 | $63,245 | $-553,366 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,491 | 1,336 | 856 | 349 | 10,813 |
| Other Financing Activity | 73,948 | 0 | 0 | 0 | 601,651 |
| Financing Cash Flow | $76,439 | $1,336 | $856 | $349 | $612,464 |
| Exchange Rate Effect | -8 | -17 | -11 | 1 | -148 |
| Beginning Cash Position | 26,676 | 26,676 | 26,676 | 26,676 | 55,516 |
| End Cash Position | 165,810 | 100,376 | 33,880 | 37,940 | 26,676 |
| Net Cash Flow | $139,134 | $73,700 | $7,204 | $11,264 | $-28,840 |
| Free Cash Flow | |||||
| Operating Cash Flow | -278,685 | -193,395 | -99,392 | -52,331 | -87,790 |
| Free Cash Flow | -278,685 | -193,395 | -99,392 | -52,331 | -87,790 |